Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
D HansenHelen LingTammaryn LashleyJennifer A FoleyC StrandT M EidJ L HoltonThomas Treharne WarnerPublished in: Neuropathology and applied neurobiology (2020)
This is the first study which identified prominent concurrent CAA pathology as a pathological substrate of DLB. More prominent CAA and rapid disease progression as measured by clinical milestones distinguish DLB from PDD.